StocksFin Logo
TAK logo
$TAK

Takeda Pharmaceutical Company Limited

TAK country of incorporation
|
https://www.takeda.com
|
Mr. Christophe Weber
|
47,347 employees
NYSE | Healthcare | Drug Manufacturers—Specialty & Generic
TAK reported its Q223 earnings on September 30, 2022 (103 weeks ago).
$1T 18.6% vs. Q222 Revenues Q223
69.53% 3.2% vs. Q222 Gross Profit Margin
6.16% 13.2% vs. Q222 Net Profit Margin
180.38B -4.9% vs. Q222 Free Cash Flow Q223
$10 0% vs. Q222 EPS Q223
Company Card Q223
As reported on September 30, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Company Card Q223
As reported on September 30, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B+
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2023 Not reported yet.
Q22023
1T
+3.1%
305.45B
61.74B
-41.2%
$10
Q12023
972.47B
292.88B
105.01B
$10
FY2022
3.57T
 1.11T
230.06B
$10
Q42022
873.29B
-3.1%
308.38B
-11.36B
-119.7%
$-3.63
Q32022
901.29B
+6.7%
281.41B
57.77B
+25.7%
$10
Q22022
844.82B
-11%
275.8B
45.96B
-66.6%
$10
Q12022
949.6B
241.26B
137.68B
$10
FY2021
3.2T
 994.31B
376.01B
$10
FY2020
3.29T
 1.09T
44.24B
$10
FY2019
2.1T
 659.69B
109.13B
$10
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2023 Not reported yet.
Q22023
14.59T
 7.88T
798.14B
4.74T
6.71T
Q12023
14.07T
 7.75T
645.99B
4.6T
6.32T
FY2022
13.18T
 7.49T
849.7B
4.55T
5.68T
FY2021
12.91T
 7.74T
966.22B
4.66T
5.17T
FY2020
12.82T
 8.09T
637.61B
5.68T
4.72T
FY2019
13.87T
 8.71T
702.09B
6.74T
5.16T
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2023 Not reported yet.
Q22023
220.99B
 -27.21B
-51.88B
-40.61B
180.38B
+1376.2%
Q12023
84.24B
 -94.71B
-215.72B
-98.38B
-14.14B
FY2022
1.12T
 -198.13B
-1.07T
-186.04B
937.07B
FY2021
1.01T
 393.53B
-1.09T
-236.47B
774.46B
FY2020
669.75B
 292.12B
-1.01T
-217.71B
452.04B
FY2019
328.48B
 -2.84T
2.95T
-134.11B
194.37B
Institutional Ownership
Dividend History
Date Amount
Sep 29, 2021 $0.4
Mar 30, 2021 $0.41
Sep 29, 2020 $0.43
Mar 30, 2020 $0.42
Sep 27, 2019 $0.41
Mar 28, 2019 $0.42
Sep 27, 2018 $0.4
Mar 28, 2018 $0.41
Number of Employees